HOME >> MEDICINE >> NEWS
Fatigue a lasting problem after liver transplantation

A new study on fatigue experienced by patients after undergoing liver transplantation found that it is a major problem that does not tend to improve with the passage of time. Liver transplant patients experience physical fatigue and reduced activity rather than mental fatigue and reduced motivation.

The results of this study appear in the June 2006 issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS). The journal is published on behalf of the societies by John Wiley & Sons, Inc. and is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/livertransplantation.

Although fatigue is common in end-stage liver disease and can even contribute to the need for a liver transplant, few studies have been conducted on fatigue after liver transplants take place. In the current study, researchers led by Rita van den Berg-Emons, Ph.D. of the Department of Rehabilitation Medicine at the Erasmus Medical Center in Rotterdam, The Netherlands, assessed 96 liver transplant patients who visited the hospital's outpatient clinic between February and June 2003. The patients were given a series of self-administered questionnaires: the Fatigue Severity Scale (FSS) measured fatigue severity; the Multidimensional Fatigue Inventory (MFI-20) measured the nature of fatigue; two additional questionnaires measured the patients' disability level and their health-related quality of life (HRQoL). In addition, the researchers assessed patients' age, gender, reason for having the transplant, time since the transplant took place, and the number of immunosuppressive agents they were taking.

The results showed that 66 percent of the patients were fatigued, 44 percent were severely fatigued, and there was no indication that fatigue lessened over time. "T
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
1-Jun-2006


Page: 1 2 3

Related medicine news :

1. Fatigue and breast cancer survivors
2. Benefits of trastuzumab are lasting, reducing both HER2 + breast cancer deaths and recurrence
3. New allergy vaccine provides long-lasting hay fever relief after just 6 weeks of shots
4. Maintenance therapies offer lasting heart health benefits
5. Procedure for irregular heartbeat gives long-lasting relief & improves quality of life
6. Significant number of emphysema patients would find lasting benefit from lung surgery
7. MabThera A unique approach providing lasting benefits for patients with rheumatoid arthritis
8. IBS study shows that targeted antibiotics lead to long-lasting improvement in symptoms
9. Neuroscientists identify how trauma triggers long-lasting memories in the brain
10. Cognitive therapy works as well as antidepressants, but with lasting effect after therapy ends
11. Drug for cluster headaches may cause heart problems

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Fatigue lasting problem after liver transplantation

(Date:7/25/2014)... (PRWEB) July 25, 2014 AttorneyOne.com, a recognized ... latest information from the FDA on Ibuprofen and Oxcarbazepine ... that one lot of Ibuprofen and one lot of Oxcarbazepine ... due to mislabeled packaging. Oxcarbazepine is used for the treatment ... , The reason for the recall is that Lot ...
(Date:7/25/2014)... July 25, 2014 Parker Waichman LLP, ... of consumers comments on a recent tobacco lawsuit in ... smoker $23.6 billion in punitive damages. Cynthia Robinson brought ... cigarettes. The case is Cynthia Robinson v. R.J. Reynolds ... Florida First Circuit Court, Escambia County, Florida; Case Number ...
(Date:7/25/2014)... Drexel University College of Medicine is pleased ... been appointed vice dean for education, effective October 1, 2014. ... Medical College, where she is currently chair of the Department ... of medicine. , As a member of the senior ... major role in many aspects of the development of the ...
(Date:7/25/2014)... vulnerable neurons and reduce motor deficits in a ... University School of Medicine have shown. , The ... Parkinson,s Disease . , The findings demonstrate that ... at sufficient levels and have beneficial effects when ... Previous studies of XPro1595 in animals tested more ...
(Date:7/25/2014)... 25, 2014 The new report ... Feed, Pharmaceuticals and Others), by Type (Amylases, Cellulases, ... Geography - Global Trends & Forecasts to 2019", ... of the global Carbohydrase market with analysis of ... is segmented and values are forecasted on the ...
Breaking Medicine News(10 mins):Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 2Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 3Health News:Anti-inflammatory drug can prevent neuron loss in Parkinson's model 2Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 2Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 3Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 4
(Date:7/24/2014)... 24, 2014  Uroplasty, Inc. (NASDAQ: UPI ... and markets innovative proprietary products to treat voiding ... 2015 first quarter ended June 30, 2014.  ... Neuromodulation System grew 19% to $4.1 million, as ... of the prior year.  Total revenue for the ...
(Date:7/24/2014)... July 24, 2014 Amgen (NASDAQ: AMGN ... financial results on Tuesday, July 29, 2014, after the close ... by a conference call with the investment community at 2 ... Robert A. Bradway , chairman and chief executive officer, ... Live audio of the conference call will be simultaneously broadcast ...
(Date:7/24/2014)... British Columbia and MENLO PARK, Calif. ... Inc. (OTCQB: DMPI) ("DelMar" "the company") announced today that ... company,s fiscal year from December 31 to June 30. Accordingly, ... September 30, 2014. Jeffrey Bacha , president ... end is an important step in achieving our goal of ...
Breaking Medicine Technology:Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11Amgen Announces Webcast of 2014 Second Quarter Financial Results 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3
Cached News: